Prefibrotic Primary Myelofibrosis

hematologic malignancy

Identifier: CI-CAN-00008289
Entity page: /cancer/prefibrotic-primary-myelofibrosis ↗
Edges: 15

Neighbours: 7 drugs8 trials
Drawn: 15 of 15 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Prefibrotic Primary Myelofibrosis investigated in trials for …INVESTIGATED_IN_TRIALSderived7 of 7
→ investigated in trials for	Aspirinsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants

Prefibrotic Primary Myelofibrosis studied in …STUDIED_INderived8 of 8
→ studied in	NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05198960Phase 3 · recruiting AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT04942080NA · recruiting Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI) · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT03869476NA · completed Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms. · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT06371573completed Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT05882773recruiting Asian Myeloproliferative Neoplasm (MPN) Registry · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT03121599NA · terminated 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT02528877Phase 1 · withdrawn Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis · condition mapped ALIAS · 8 trials mapped (4 active)	—	—	Prefibrotic Primary Myelofibrosis	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains